| abstract |
Anti-IL17A / F antibodies are provided that bind to both IL-17A and IL-17F and inhibit the activity of both IL-17A and IL-17F. The antibody contains heavy chain CDRs 1 to 3 represented by SEQ ID NOS: 1 to 3, and light chain CDRs 1 to 3 represented by SEQ ID NOS: 4 to 6, respectively. Provided is the use of an antibody in the manufacture of a medicament for the treatment of IL-17A and / or IL-17F related diseases in a subject, and a pharmaceutical composition comprising said antibody. |